It has been reported that miR-137 induces differentiation of brain tumor stem cells and inhibits proliferation of GBM cells by post-transcriptional repression of cyclin-dependent kinase 6 (CDK6) (34). This evidence concerns the gene CDK6 and glioblastoma.